Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. - Wikidata - wikimedia - TriplyDB

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

http://www.wikidata.org/entity/Q35019423

about

Lupus Nephritis: A Different Disease in European Patients?Unmet medical needs in systemic lupus erythematosus Biomarkers for childhood-onset systemic lupus erythematosus A treatment algorithm for children with lupus nephritis to prevent developing renal failure I too, am America: a review of research on systemic lupus erythematosus in African-Americans Risk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis.A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States Kidney transplantation in patients with systemic lupus erythematosus.Comparison of mortality of ESRD patients with lupus by initial dialysis modality ESRD from lupus nephritis in the United States, 1995-2010 The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States.Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis Systemic lupus erythematosus in children and adolescents.Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka Relationship of cell-free urine MicroRNA with lupus nephritis in children.Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004 The frequency and outcome of lupus nephritis: results from an international inception cohort study.Biomarkers and updates on pediatrics lupus nephritis.Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality.Improving outcomes in patients with lupus and end-stage renal disease.Differential immunotoxicity induced by two different windows of developmental trichloroethylene exposure.Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.Recent progress in the treatment of lupus nephritis.Minimising steroids in lupus nephritis--will B cell depletion pave the way?Top 10 developments in lupus nephritis.A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

P2860

Q26740483-B83283CA-2750-4899-BA70-2CA48EDA038E Q27005906-BE1AA121-DA2D-49D8-B6AC-C08490951B49 Q27007470-AA44E7C5-393A-45F6-9123-695F6516B473 Q27026880-E8464875-5092-46A1-9A66-661D0F6F2213 Q28069750-FDF82D0C-D499-40D2-8EE3-D0B7DCE979D3 Q30576975-3BAE61C9-CE75-4633-99AB-4B70F697804D Q31029893-4219EBBB-9962-4EA8-95AF-9BF4C0FD26AE Q33945242-DF2F70E3-6CF9-49AA-B1CC-90F56C12E1A5 Q34397379-D3476115-F155-46CA-9489-B0AAFE297215 Q34455158-C8C91C99-E800-4A55-8DFB-CA27E5CA22E4 Q35051164-B11621C5-CA3E-46DB-8197-DFE18BB4747F Q35132495-9D429103-0F25-4168-B306-7F0A234F3462 Q35209132-CBF3F42E-8A92-420B-AE94-0AE4EF302B8F Q35321704-A8840E2E-60BA-46E4-97AE-3B0E099E5D09 Q35544692-859B8BA2-50A6-41AC-A2C4-A8FDC1D00E92 Q35583267-FD5AFA0E-B0A7-4368-987E-40515F9FB427 Q35622817-1DC007E0-3432-4FB5-B144-A3B13A6984D5 Q35655534-6F0E2B57-0C48-4869-8F23-AA67F551C2A7 Q35890096-D5247B3D-BAF1-4806-A38C-0DA647CC9747 Q35947491-366A4BBB-4A05-460F-8C44-42F48CDC88A3 Q36070687-987F85FD-B8E3-4D7E-8E41-5E54498A630A Q36221407-2EA107EB-334B-432F-B75C-42E58CB7714A Q36265568-5A930CBD-F7C5-40A0-AC5E-B65B1781DA3B Q36265699-0BC1A524-692E-4D99-A924-37EB10D17E3A Q36266807-16F9123C-C64E-4B17-9B37-6593D38ECA08 Q36461674-7FFA8474-BDCC-48E4-9D36-2D3C663D1E6A Q36517240-E386149C-6C74-40F2-8D32-1F723EB387E3 Q36540787-90E227AC-31B4-4087-A6A8-A76147DF395A Q36608536-211FDEC7-26B9-43BD-BC89-C60DC5922466 Q37069392-9C967397-9F23-46C1-AB85-0712470C2555 Q37082037-3A02E986-AB38-44BC-962D-B11F24099D70 Q37167062-20A26C85-7F09-4625-B904-FA77554F726B Q37176237-455158D9-61B6-4C6B-9DA8-496EF1B86884 Q37522782-8E2D5BEA-D31C-411B-9D3C-2E8D7BBC4018 Q37631577-33766693-728D-4C42-B728-92CDFED745D4 Q37684471-4633FB73-2F99-46CA-96D5-BE28827BAA47 Q38010014-5373BEE8-9B57-4855-B13D-5A45CBEEC9C6 Q38095864-8250DFDA-8FF5-4928-B809-952961CC6D10 Q38124761-A1A93F6D-5B88-4810-87BE-A8C6C1063712 Q38409092-4E513211-15B9-4233-9DA0-C67A31A1FA27

P2860

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

http://www.wikidata.org/entity/Q35019423

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@ast

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@en

type

label

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@ast

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@en

prefLabel

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@ast

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@en

P1433

Q35019423-EB6B6EBE-4149-46F6-9CA7-3AD02DB4F24D

P1476

Q35019423-1515566A-6A3C-48D6-865D-77AF38BBE843

P2093

Q35019423-020B84E6-962F-4DF4-861D-4FA55964D7D7

Q35019423-1E3DD26F-F3A4-4B90-85E5-A20650B9057F

Q35019423-325B7BC4-05F7-4CB7-8188-4EEACC59B7CB

Q35019423-34540F7A-1D73-4109-AF3E-E4E338C0452F

Q35019423-4904D55F-FD22-4042-9FC4-9702D7B41E95

Q35019423-65E64A2D-D62E-4425-B5CD-6A1C25F359C2

Q35019423-71227A3E-AD6E-44CF-80E4-9AF3ED48977E

Q35019423-7998FD29-CEEF-41D5-AC92-1B567BF9B5C2

Q35019423-9E8EA71B-B3C6-4868-8ED1-21FA76F5AD5B

Q35019423-D58B4ACE-E448-450E-ACDB-EB4C4EE971F8

P2860

Q35019423-0EDEA319-B652-4E55-AD33-385BD21CAC71

Q35019423-19A35FF9-1C60-4093-B6B1-F49FF1664045

Q35019423-35BE5E05-8BEB-4B7D-9DC3-324E94A88185

Q35019423-4166298F-6F06-4897-B801-8B8F49F59EDB

Q35019423-57E44969-1CC5-4D3C-B9BC-764D08380269

Q35019423-6374A3C7-0B87-4772-87A4-3996C49A42C0

Q35019423-6B04FE59-AA25-45DB-82E5-EF4F06CA317E

Q35019423-711670D8-FADB-4DBB-A758-CBDCD032EAC5

Q35019423-78A43615-EF4C-473D-9D24-407B72E88AA3

Q35019423-8008DC21-CBAC-4A85-B851-37A9FC8A8880

P304

Q35019423-5E78D90F-233D-4DCD-A620-FE8D568388C5

P31

Q35019423-53909B9C-CB92-45D2-8341-5ABFCE6A3261

P356

Q35019423-DAB13DA0-8F37-45F5-A9B5-CC0A7D751583

P433

Q35019423-684F5EAE-B70B-4C00-ADB3-17204D500940

P478

Q35019423-7AD826C5-87B2-4CF2-8701-3C28B6AEE04C

P577

Q35019423-1D087035-1109-4E85-932D-F3F2E07551DC

P5875

Q35019423-A7E3D3B2-8A90-4089-8377-D7F892BE6556

P698

Q35019423-BC52420A-3D03-45F7-9794-77A61C9DF0DD

P921

Q35019423-28489A82-094D-4637-BAFB-6D554A7A77A2

P932

Q35019423-3E94CD43-C540-4056-8FC9-2221D156390C

P356

P1433

Arthritis & Rheumatology

P1476

Trends in the incidence, demog ...... s in the US from 1995 to 2006.

@en

P2093

Amrita Desai

http://www.w3.org/2001/XMLSchema#string

Bing Lu

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Elena Massarotti

http://www.w3.org/2001/XMLSchema#string

Graciela S Alarcón

http://www.w3.org/2001/XMLSchema#string

Karen H Costenbader

http://www.w3.org/2001/XMLSchema#string

Linda T Hiraki

http://www.w3.org/2001/XMLSchema#string

M Alan Brookhart

http://www.w3.org/2001/XMLSchema#string

Tamara Shaykevich

http://www.w3.org/2001/XMLSchema#string

Wolfgang C Winkelmayer

http://www.w3.org/2001/XMLSchema#string

P2860

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution

Lupus nephritis.

Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995.

Renal transplantation in lupus nephritis.

Geographic and temporal trends in peritoneal dialysis services in the United States between 1995 and 2003.

Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.

The future of peritoneal dialysis in the United States: optimizing its use.

Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis.

P304

1681-1688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.30293

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50893008

http://www.w3.org/2001/XMLSchema#string

P698

21445962

http://www.w3.org/2001/XMLSchema#string

P921

P932

3106117

http://www.w3.org/2001/XMLSchema#string